Cardiovascular Outcomes With GLP-1 Receptor Agonists in Type 2 Diabetes AJMCtv 7:17 7 years ago 1 739 Скачать Далее
Optimizing Cardiovascular Outcomes in Type 2 Diabetes: Beyond A1C Goals HMP Education 1:29:07 4 years ago 724 Скачать Далее
Benefits of SGLT2 Inhibitors and GLP-1 Receptor Agonists Harvard Medical School Continuing Education 6:11 2 years ago 5 960 Скачать Далее
Cardiovascular Disease Burden in Type 2 Diabetes: Strategies to Improve Outcomes HMP Education 44:17 4 years ago 3 939 Скачать Далее
Prof Melanie Davies - 'Do GLP-1 analogues and SGLT2 inhibitors have a role beyond type 2 diabetes?' At the Limits - Leading Medical Education 26:43 5 years ago 2 052 Скачать Далее
Using GLP1 receptor agonists to treat cardiac patients with diabetes Ted Rogers Centre for Heart Research 13:54 5 years ago 8 392 Скачать Далее
Type 2 Diabetes: New Guidelines and Controversies UWDeptMedicine 58:42 5 years ago 2 303 Скачать Далее
Cardiovascular and Renal Outcomes in Type 2 Diabetes Medications with Dr. Marie McDonnell NEJM Group 40:56 4 months ago 20 Скачать Далее
SGLT2 Inhibitors vs GLP-1 Agonists: A Cardiologist and an Endocrinologist Weigh In Medscape 15:34 2 years ago 10 335 Скачать Далее
Protocols for Safe Use of SGLT2i and GLP1RA in the Hospital Setting University of Ottawa Heart Institute 50:30 4 years ago 3 045 Скачать Далее
